Search
Feed aggregator
With Latest Expansion in Ohio, Resilience Can Best Serve Partners and Patients
With Latest Expansion in Ohio, Resilience Can Best Serve Partners and Patients 6/28/2024
Illumina Reports $1.47B ‘Goodwill’ Impairment Charge After Grail Spinoff
Illumina Reports $1.47B ‘Goodwill’ Impairment Charge After Grail Spinoff 6/28/2024
AbbVie Expands Immuno Portfolio With $250M Celsius Buy as Humira Hits Patent Cliff
AbbVie Expands Immuno Portfolio With $250M Celsius Buy as Humira Hits Patent Cliff 6/28/2024
Merck’s ADC Pact With Daiichi Hits Regulatory Setback in FDA Rejection
Merck’s ADC Pact With Daiichi Hits Regulatory Setback in FDA Rejection 6/27/2024
Verona Wins FDA Approval for COPD Drug, Eyes Q3 Launch With $1B Financing for Rollout
Verona Wins FDA Approval for COPD Drug, Eyes Q3 Launch With $1B Financing for Rollout 6/27/2024
Novo Ends Phase III Kidney Disease Trial, Incurs More Than $800M Q2 Impairment Loss
Novo Ends Phase III Kidney Disease Trial, Incurs More Than $800M Q2 Impairment Loss 6/27/2024
AbbVie, Genmab Secure FDA Label Expansion for Epkinly in Follicular Lymphoma
AbbVie, Genmab Secure FDA Label Expansion for Epkinly in Follicular Lymphoma 6/27/2024
CDC Narrows RSV Vaccine Recommendations for Seniors
CDC Narrows RSV Vaccine Recommendations for Seniors 6/27/2024
New Team, Same Company: How to Transition to Your New Role
New Team, Same Company: How to Transition to Your New Role 6/27/2024
Leadership Lab: 3 Strategies for an Executive’s Discreet Job Search
Leadership Lab: 3 Strategies for an Executive’s Discreet Job Search 6/27/2024
5 Top Companies Hiring in the Washington, D.C., Area
5 Top Companies Hiring in the Washington, D.C., Area 6/27/2024
Lyell Reports Patient Death in Early-Stage CAR T Trial, Shows Otherwise Strong Response Rate
Lyell Reports Patient Death in Early-Stage CAR T Trial, Shows Otherwise Strong Response Rate 6/26/2024
Zealand to Raise $1B in Public Offering to Fund Obesity Candidates
Zealand to Raise $1B in Public Offering to Fund Obesity Candidates 6/26/2024
Curie.Bio Adds $380M Series A Fund to Move Biotech Startups to Clinic
Curie.Bio Adds $380M Series A Fund to Move Biotech Startups to Clinic 6/26/2024
Lilly Teams With OpenAI to Tackle Threat of Drug-Resistant Bacteria
Lilly Teams With OpenAI to Tackle Threat of Drug-Resistant Bacteria 6/26/2024
Wave Clears Phase Ib/IIa Study in Huntington’s Disease, Eyes Accelerated Approval
Wave Clears Phase Ib/IIa Study in Huntington’s Disease, Eyes Accelerated Approval 6/26/2024
Teva Pays $750M to Resolve Israeli Tax Issues Going Back More Than a Decade
Teva Pays $750M to Resolve Israeli Tax Issues Going Back More Than a Decade 6/26/2024
How Pfizer, Bristol Myers Squibb and Johnson & Johnson Are Confronting Patent Cliffs
How Pfizer, Bristol Myers Squibb and Johnson & Johnson Are Confronting Patent Cliffs 6/26/2024
Sarepta’s Big DMD Approval, Alnylam’s Clinical Win and ADA Highlights
Sarepta’s Big DMD Approval, Alnylam’s Clinical Win and ADA Highlights 6/26/2024
After Full Approval, Sarepta Lays Out Its Next Moves
After Full Approval, Sarepta Lays Out Its Next Moves 6/26/2024
World Pharma News
- U.S. FDA grants full approval to Pfizer's BRAFTOVI combination regimen in first-line metastatic colorectal cancer
- New antibody-drug conjugate strategy to block HIV infection
- Rhododendron-derived drugs now made by bacteria
- Lung cancer drug offers a surprising new treatment against ovarian cancer
- Researchers identify promising Alzheimer's disease drug target